Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase
Joaquim Peraire(Instituto de Salud Carlos III), Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Ciara K. O’Sullivan(Institució Catalana de Recerca i Estudis Avançats), Óscar M. Peiró(Institut de Recerca Biomèdica Catalunya Sud), Sonia Espineira(Institut de Recerca Biomèdica Catalunya Sud), Sílvia Chafino(Instituto de Salud Carlos III), Vasso Skouridou(Hospital Sant Pau i Santa Tecla), Laia Reverté(Institute for Research and Technology in Food and Agriculture), Fréderic Gómez-Bertomeu, Maryluz Botero-Gallego(Hospital Sant Pau i Santa Tecla), Montserrat Olona(Institut de Recerca Biomèdica Catalunya Sud), Graciano García‐Pardo(Instituto de Salud Carlos III), Alba Sánchez(Institut de Recerca Biomèdica Catalunya Sud), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud)
Cited by 4
Related Papers
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013
|Journal of Infection|2016|89
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
|EBioMedicine|2019|81
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
|Journal of Virology|2017|78